TY - JOUR
T1 - Swelling-activated Cl- currents and intracellular CLC-3 are involved in proliferation of human pulmonary artery smooth muscle cells
AU - Liang, Wenbin
AU - Huang, Lihong
AU - Zhao, Dongling
AU - He, Jeff Z.
AU - Sharma, Parveen
AU - Liu, Jie
AU - Gramolini, Anthony O.
AU - Ward, Michael E.
AU - Cho, Hee Cheol
AU - Backx, Peter H.
PY - 2014/2
Y1 - 2014/2
N2 - Background: Proliferation of pulmonary artery smooth muscle cells (PASMCs) leads to adverse vascular remodeling and contributes to pulmonary arterial hypertension, a condition associated with a 15% annual mortality despite treatment. We previously showed that swelling-activated Cl- currents (ICl,swell) are upregulated in PASMC proliferation and that nonspecific Cl- current blockers inhibit proliferation. However, the specific role of ICl,swell in PASMC proliferation and its molecular underpinning remain unknown. Methods and results: In the present study, we found that the specific ICl,swell blocker, DCPIB (4-[(2-butyl-6,7- dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy] butanoic acid), dose-dependently blocked (IC50=2.7μmol/l) ICl,swell and inhibited (IC50=6.9μmol/l) proliferation in isolated human PASMCs (hPASMCs). To identify the Cl- channel genes underlying I Cl,swell and regulating hPASMC proliferation, we measured the mRNA expression of candidate Cl- channel genes (CLC-1 to CLC-7, CLC-Ka and CLC-Kb, and BEST-1 to BEST-4) in hPASMCs. CLC-2 to CLC-7 and BEST-1 are expressed in hPASMCs, with the most abundant gene being CLC-3, a channel gene previously linked to ICl,swell. Although stable expression of a microRNA-adapted shRNA targeting CLC-3 transcripts in hPASMCs selectively reduced CLC-3 mRNA by more than 80% and inhibited hPASMC proliferation (by >45%) compared with control-shRNA, it did not alter ICl,swell. Consistent with this observation, immunocytostaining studies revealed that CLC-3 protein is primarily located in intracellular areas of cultured proliferative hPASMCs. The intracellular CLC-3 protein levels were profoundly reduced by shRNA targeting CLC-3. The other molecular candidate for ICl,swell (i.e.,CLC-2) also showed a mainly intracellular distribution. Conclusion: Our findings support the conclusion that both ICl,swell and CLC-3 play a role in PASMC proliferation, but CLC-3 channels do not underlie ICl,swell in these cells.
AB - Background: Proliferation of pulmonary artery smooth muscle cells (PASMCs) leads to adverse vascular remodeling and contributes to pulmonary arterial hypertension, a condition associated with a 15% annual mortality despite treatment. We previously showed that swelling-activated Cl- currents (ICl,swell) are upregulated in PASMC proliferation and that nonspecific Cl- current blockers inhibit proliferation. However, the specific role of ICl,swell in PASMC proliferation and its molecular underpinning remain unknown. Methods and results: In the present study, we found that the specific ICl,swell blocker, DCPIB (4-[(2-butyl-6,7- dichloro-2-cyclopentyl-2,3-dihydro-1-oxo-1H-inden-5-yl)oxy] butanoic acid), dose-dependently blocked (IC50=2.7μmol/l) ICl,swell and inhibited (IC50=6.9μmol/l) proliferation in isolated human PASMCs (hPASMCs). To identify the Cl- channel genes underlying I Cl,swell and regulating hPASMC proliferation, we measured the mRNA expression of candidate Cl- channel genes (CLC-1 to CLC-7, CLC-Ka and CLC-Kb, and BEST-1 to BEST-4) in hPASMCs. CLC-2 to CLC-7 and BEST-1 are expressed in hPASMCs, with the most abundant gene being CLC-3, a channel gene previously linked to ICl,swell. Although stable expression of a microRNA-adapted shRNA targeting CLC-3 transcripts in hPASMCs selectively reduced CLC-3 mRNA by more than 80% and inhibited hPASMC proliferation (by >45%) compared with control-shRNA, it did not alter ICl,swell. Consistent with this observation, immunocytostaining studies revealed that CLC-3 protein is primarily located in intracellular areas of cultured proliferative hPASMCs. The intracellular CLC-3 protein levels were profoundly reduced by shRNA targeting CLC-3. The other molecular candidate for ICl,swell (i.e.,CLC-2) also showed a mainly intracellular distribution. Conclusion: Our findings support the conclusion that both ICl,swell and CLC-3 play a role in PASMC proliferation, but CLC-3 channels do not underlie ICl,swell in these cells.
KW - 3-dihydro-1-oxo-1H-inden-5- yl)oxy] butanoic acid
KW - 4-[(2-Butyl-6
KW - 7-dichloro-2-cyclopentyl-2
KW - CLC-3
KW - proliferation
KW - pulmonary arterial hypertension
KW - RNAi
UR - http://www.scopus.com/inward/record.url?scp=84892979752&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892979752&partnerID=8YFLogxK
U2 - 10.1097/HJH.0000000000000013
DO - 10.1097/HJH.0000000000000013
M3 - Article
C2 - 24284495
AN - SCOPUS:84892979752
SN - 0263-6352
VL - 32
SP - 318
EP - 330
JO - Journal of Hypertension
JF - Journal of Hypertension
IS - 2
ER -